Enliven Therapeutics Inc. (ELVN) Stock Analysis

Enliven Therapeutics Inc. (ELVN) is a publicly traded company in the HEALTHCARE sector. It trades at $35.52, carries a market capitalization of $2.28B. This page summarizes the public market data, fundamentals, and frequently asked questions for ELVN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $35.52
• Market Cap: $2.28B
• EPS: $-1.64
• 52-Week High: $48.53
• 52-Week Low: $14.79

Market Sentiment

Enliven Therapeutics Inc. currently has a Bullish sentiment score of 0.35.

About Enliven Therapeutics Inc.

None

GNG Research Analysis

GNG Research scores Enliven Therapeutics Inc. (ELVN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ELVN.

Frequently Asked Questions

Does ELVN pay dividends?

Enliven Therapeutics Inc. (ELVN) does not currently pay a regular dividend.

What is ELVN's market cap?

Enliven Therapeutics Inc. (ELVN) has a market capitalization of $2.28B with a current stock price of $35.52.